Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Cancer Imaging and Image-directed Interventions

This article is part of the Research TopicArtificial Intelligence Advancing Lung Cancer Screening and TreatmentView all 10 articles

Development and validation of an LDCT-based deep learning radiomics nomogram for predicting postoperative recurrence of stage Ia lung adenocarcinoma

Provisionally accepted
Haimei  LanHaimei Lan*Chaosheng  WeiChaosheng WeiMingzhuang  LiaoMingzhuang LiaoHongfeng  LiangHongfeng LiangJianli  QinJianli QinJixing  YiJixing YiFengming  XuFengming XuDandan  HuangDandan HuangMeiqing  ZhangMeiqing ZhangFeng  QingFeng QingTao  LiTao Li*
  • Liuzhou Workers' Hospital, Liuzhou, China

The final, formatted version of the article will be published soon.

Objective: This study wanted to use low-dose computed tomography (LDCT) plain scan images to create a deep learning radiomic nomogram (DLRN) to accurately predict the likelihood of recurrence after surgery in patients with stage Ia lung adenocarcinoma (LUAD). Methods: We collected cases from January 2010 to December 2020 at Center 1 who underwent surgery and were pathologically diagnosed with stage Ia LUAD, and additionally collected patients with the same criteria at Center 2 from January 2015 to December 2018 for external validation. Deep learning and radiomic feature extraction were performed on LDCT images of all patients. In the deep learning and radiomics methods, we tested multiple different models and selected the best model based on the results of the internal validation cohort. Finally, we construct a nomogram by combining deep learning features, radiomics features and clinical data. Subsequently, We used the receiver operating characteristic (ROC) curve to check how well these models performed in terms of diagnosis. The calibration degree of each model was evaluated using calibration curves, while the clinical value of each model was assessed through decision curve analysis (DCA). Results: In Center 1, we collected a total of 233 eligible patients, who were randomly divided into a training cohort (163 patients) and an internal validation cohort (70 patients) at a 7:3 ratio. And we collected included a total of 89 patients in Center 2. Internal validation results showed Resnet50 and Logistic Regression (LR) as optimal models for deep learning and radiomics approaches, respectively. The area under the curve (AUC) values for this combined model were 0.972 (95% CI: 0.949-0.995) in the training cohort, 0.925 (95% CI: 0.845-1.000) in the internal validation cohort, and 0.915 (95% CI: 0.853-0.976) in the external validation cohort. Compared with other single models, it demonstrated the best performance. Conclusion: Preoperative DLRN based on LDCT plain scan images exhibit good predictive value for postoperative recurrence in patients with stage Ia LUAD. The present study developed a novel prognostic assessment method with the objective of assisting clinicians in refining adjuvant treatment plans for patients with stage Ia LUAD, thus facilitating personalised prognostic management.

Keywords: Deep Leraning Radiomics Nomogram, Low-dose computed tomography, Lung Adenocarcinoma, predictive model, Resnet50

Received: 15 Sep 2025; Accepted: 16 Dec 2025.

Copyright: © 2025 Lan, Wei, Liao, Liang, Qin, Yi, Xu, Huang, Zhang, Qing and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Haimei Lan
Tao Li

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.